Isogenic human iPSC Parkinson's model shows nitrosative stress-induced dysfunction in MEF2-PGC1α transcription.
Level 5 - mechanism / opinion, no new human data
In vitro bench research using human iPSC-derived neurons.
PubMed 24290359 · doi:10.1016/j.cell.2013.11.009
What was done
The authors used patient-derived induced pluripotent stem cells (iPSCs) differentiated into A9 dopaminergic neurons to compare A53T α-synuclein mutant cells against isogenic mutation-corrected controls. They evaluated cellular responses to basal conditions and environmental mitochondrial toxins (paraquat, maneb, and rotenone), assessed S-nitrosylation of transcription factor MEF2C and its effect on MEF2C-PGC1α transcription and apoptotic cell death, and conducted small-molecule high-throughput screening to identify potential modulators.
What was found
The abstract reports no numerical data or effect sizes. Qualitatively, A53T mutant neurons exhibited basal and toxin-induced nitrosative/oxidative stress that caused S-nitrosylation of MEF2C compared to isogenic controls. This modification inhibited the MEF2C-PGC1α transcriptional network, contributing to mitochondrial dysfunction and apoptosis. High-throughput screening flagged the MEF2C-PGC1α axis as a potential drug target.
Why it matters
The study provides a molecular mechanism for gene-environment interactions in Parkinson's disease, showing how environmental toxins and α-synuclein mutations converge to disrupt mitochondrial transcription via S-nitrosylation.
Limits
This is purely preclinical in vitro research in cultured iPSC-derived neurons, which cannot fully replicate the aging human brain or systemic pathology. The abstract reports no quantitative measurements, confidence intervals, or specific chemical hits from the high-throughput screen.
Cited by
- supports The dithiocarbamate pesticides maneb and mancozeb are used in laboratory research to model Parkinson's disease by damaging cellular and mitochondrial function.